Gainers
- Celularity (NASDAQ:CELU) shares moved upwards by 36.8% to $1.98 during Thursday's regular session. The market value of their outstanding shares is at $43.6 million. As per the news, the Q2 earnings report came out today.
- Coherus BioSciences (NASDAQ:CHRS) shares moved upwards by 31.25% to $0.95. The market value of their outstanding shares is at $109.4 million. As per the press release, Q3 earnings came out yesterday.
- Emergent BioSolutions (NYSE:EBS) shares increased by 30.76% to $12.03. The market value of their outstanding shares is at $630.3 million. As per the news, the Q3 earnings report came out yesterday.
- Ensysce Biosciences (NASDAQ:ENSC) stock increased by 29.17% to $0.71. The market value of their outstanding shares is at $10.6 million.
- Psyence Biomedical (NASDAQ:PBM) stock rose 23.03% to $0.08. The market value of their outstanding shares is at $4.0 million.
- Myomo (AMEX:MYO) shares rose 19.61% to $5.0. The company's market cap stands at $151.1 million. As per the press release, Q3 earnings came out yesterday.
Losers
- Xilio Therapeutics (NASDAQ:XLO) shares fell 28.7% to $0.92 during Thursday's regular session. The company's market cap stands at $40.4 million.
- Dentsply Sirona (NASDAQ:XRAY) shares fell 24.69% to $18.06. The company's market cap stands at $3.6 billion. As per the news, the Q3 earnings report came out today.
- Personalis (NASDAQ:PSNL) shares declined by 19.54% to $4.49. The market value of their outstanding shares is at $296.0 million. As per the news, the Q3 earnings report came out yesterday.
- Axogen (NASDAQ:AXGN) shares decreased by 17.75% to $12.61. The company's market cap stands at $552.6 million. The company's, Q3 earnings came out today.
- Harvard Bioscience (NASDAQ:HBIO) shares fell 17.56% to $2.33. The market value of their outstanding shares is at $101.3 million. As per the press release, Q3 earnings came out today.
- Clover Health Investments (NASDAQ:CLOV) shares decreased by 16.41% to $3.64. The market value of their outstanding shares is at $1.8 billion. As per the press release, Q3 earnings came out yesterday.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
